Botox

(redirected from onabotulinumtoxinA)
Also found in: Dictionary, Medical.

Botox

™ a preparation of botulinum toxin used to treat muscle spasm and to remove wrinkles
Collins Discovery Encyclopedia, 1st edition © HarperCollins Publishers 2005
References in periodicals archive ?
Two of the RCTs included the MCC improvement data representing a cohort of 932 participants (450 in the onabotulinumtoxinA group and 482 in the control group) [Table 3].
Efficacy and safety of OnabotulinumtoxinA for idiopathic overactive bladder: A double-blind placebo controlled randomized dose ranging trial.
Abbreviations: BA = behavioral activation, BF = biofeedback, BOTOX = onabotulinumtoxinA, CAM = complementary and alternative medicine, CBT = cognitive behavioral therapy, CPT = cognitive processing therapy, DOD = Department of Defense, FDA = Food and Drug Administration, NSAID = nonsteroidal anti-inflammatory drug, OEF = Operation Enduring Freedom, OIF = Operation Iraqi Freedom, PE = prolonged exposure, PGW = Persian Gulf war, PTSD = posttraumatic stress disorder, RCT = randomized clinical trial, SNRI = serotonin-norepinephrin reuptake inhibitor, SSRI = selective serotonin reuptake inhibitor, TCA = tricyclic antidepressant, VA = Department of Veterans Affairs, VHA = Veterans Health Administration.
(8) Specifically, the senior author has used onabotulinumtoxinA ever since efficacy with hypertrophic scarring was previously demonstrated.
Ninety patients were given injections of onabotulinumtoxinA and of abobotulinumtoxinA on either side of their faces.
Which of the following has a longer duration of response than onabotulinumtoxinA?
Xeomin was first approved by the FDA in 2010 for the treatment of blepharospasm (previously treated with onabotulinumtoxinA) and cervical dystonia in adult patients and later in 2015 for upper limb spasticity in adult patients.
The classes of medications include: beta-blockers, anticonvulsants, tricyclics, calcium channel blockers, angiotensin II receptor antagonists, onabotulinumtoxinA, and valproic acid.
Irish pharmaceutical company Allergan plc (NYSE:AGN) on Friday updated the results of the clinical study of the higher dose of BOTOX Cosmetic (onabotulinumtoxinA) for the treatment of moderate to severe glabellar lines.
Intradetrusor injections of OnabotulinumtoxinA (BoNTA) has emerged as a safe and effective treatment for NDO.